104 related articles for article (PubMed ID: 708488)
1. Effect of Wy-14,643 on cholesterol metabolism in normal and hypercholesterolemic rats.
Tomarelli RM; Bauman LM; Savini S
Atherosclerosis; 1978 Aug; 30(4):301-11. PubMed ID: 708488
[No Abstract] [Full Text] [Related]
2. Studies on hypolipidemic agents. III. Comparison of the hypolipidemic properties of 5-tridecylpyrazole-3-carboxylic acid and clofibrate.
Seki K; Fukuda M; Isegawa J; Ohki M
Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4103-9. PubMed ID: 6529804
[No Abstract] [Full Text] [Related]
3. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
Digestion; 1979; 19(4):228-36. PubMed ID: 478204
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of clofibrate and halofenate (MK-185) in isolated rat hepatocytes.
Homcy CJ; Margolis S
Atherosclerosis; 1974; 19(3):381-91. PubMed ID: 4828566
[No Abstract] [Full Text] [Related]
5. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats and hamsters. I. Comparative action of clofibrate and tiadenol on hepatic and intestinal biosynthesis of cholesterol in hamsters and rats].
Rousselet F; Fredj G; Clenet M
Ann Pharm Fr; 1986; 44(4):269-76. PubMed ID: 3566092
[No Abstract] [Full Text] [Related]
6. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
Tomita T; Takeshita R; Nagakura T; Hayashi E
Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
[No Abstract] [Full Text] [Related]
7. Effects of S-8527 (1,1-bis(4'-(1'-carboxy-1'-methylpropoxy)phenyl) cyclohexane), a new hypolipidemic compound, on cholesterol and lipoprotein metabolism in rats.
Suzuki K
Biochem Pharmacol; 1976 Feb; 25(3):325-8. PubMed ID: 1267828
[No Abstract] [Full Text] [Related]
8. Increased plasma cholesterol and decreased body lipid levels in Wistar rats following pirinixil (BR 931) treatment.
Kritchevsky D; Klurfeld DM; Tepper SA; Mueller MA; Puglisi L; Sirtori CR
Pharmacol Res Commun; 1979 Jun; 11(6):475-82. PubMed ID: 504321
[No Abstract] [Full Text] [Related]
9. Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat.
Lazarow PB
Science; 1977 Aug; 197(4303):580-1. PubMed ID: 195342
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary fat saturation on absorption and intestinal secretion of cholesterol by the hypercholesterolemic rat.
McGovern RF; Quackenbush FW
Lipids; 1973 Aug; 8(8):470-2. PubMed ID: 4729076
[No Abstract] [Full Text] [Related]
11. Tissue-specific effect of clofibrate on rat lipogenic enzyme gene expression.
Karbowska J; Kochan Z; Zelewski L; Swierczynski J
Eur J Pharmacol; 1999 Apr; 370(3):329-36. PubMed ID: 10334510
[TBL] [Abstract][Full Text] [Related]
12. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.
Rozé C; Cuchet P; Souchard M; Vaille C; Debray C
Eur J Pharmacol; 1977 May; 43(1):57-64. PubMed ID: 862664
[TBL] [Abstract][Full Text] [Related]
13. Prevention of CeCl3-induced hepatotoxicity by hypolipidemic compounds.
Tuchweber B; Salas M
Arch Toxicol; 1978 Dec; 41(3):223-32. PubMed ID: 736793
[TBL] [Abstract][Full Text] [Related]
14. Potential hypolipidemic agents derived from 3-hydroxy-17,17-dimethylgona-1,3,5(10),8,11,13-hexaene.
Chinn LJ; Salamon KW
J Med Chem; 1977 Feb; 20(2):229-33. PubMed ID: 836494
[TBL] [Abstract][Full Text] [Related]
15. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
Maxwell RE; Nawrocki JW; Uhlendorf PD
Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963
[TBL] [Abstract][Full Text] [Related]
16. Oat oil lowers the plasma and liver cholesterol concentrations by promoting the excretion of faecal lipids in hypercholesterolemic rats.
Tong LT; Zhong K; Liu L; Guo L; Cao L; Zhou S
Food Chem; 2014 Jan; 142():129-34. PubMed ID: 24001822
[TBL] [Abstract][Full Text] [Related]
17. Effects of soybean phospholipid, chlorella phospholipid, and clofibrate on collagen and elastin synthesis in the aorta and on the serum and liver lipid contents in rats.
Hashimoto S; Setoyama T; Yokokura T; Mutai M
Exp Mol Pathol; 1982 Feb; 36(1):99-106. PubMed ID: 7198996
[No Abstract] [Full Text] [Related]
18. Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats.
Ohata I; Sakamoto N; Nagano K; Maeno H
Biochem Pharmacol; 1984 Jul; 33(14):2199-205. PubMed ID: 6466343
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypolipidemic drugs on hepatic CoA.
Halvorsen O
Biochem Pharmacol; 1983 Mar; 32(6):1126-8. PubMed ID: 6838659
[No Abstract] [Full Text] [Related]
20. Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.
Berge RK; Bakke OM
Biochem Pharmacol; 1981 Aug; 30(16):2251-6. PubMed ID: 7295339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
